Does VEDOLIZUMAB Cause Transient ischaemic attack? 131 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Transient ischaemic attack have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.2% of all adverse event reports for VEDOLIZUMAB.
131
Reports of Transient ischaemic attack with VEDOLIZUMAB
0.2%
of all VEDOLIZUMAB reports
0
Deaths
70
Hospitalizations
How Dangerous Is Transient ischaemic attack From VEDOLIZUMAB?
Of the 131 reports, 70 (53.4%) required hospitalization, and 2 (1.5%) were considered life-threatening.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which VEDOLIZUMAB Alternatives Have Lower Transient ischaemic attack Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB